In News

Oculogica announces patent issued for detection and diagnosis of elevated intracranial pressure via eye-tracking.

Oculogica, a neuro-diagnostic company, has been issued a patent for its novel neuro-optic tracking device, the EyeBOXCNS™, to detect elevated intracranial pressure via eye-tracking. Continued elevation of ICP is believed to be the cause of Second Impact Syndrome, which is sudden death that occurs when sports players return to play in a concussed state and suffer a second blow to the head. An eye-tracking based test for elevated ICP as a part of a concussion test are promising developments for athletes, the military, trauma patients and the medical community that serves them.

 

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=Samadani&OS=Samadani&RS=Samadani

Minnesota Daily: Clinical trial works to provide treatment for brain injuries